Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 170 | $1,086,380,708 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 24 Jun 2024 | Sale | 2 | 161.1 | 322 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 5 | 183.15 | 916 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 23 | 161.27 | 3,709 | D |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Apr 2024 | Sale | 60 | 150.85 | 9,051 | I |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 20 Sep 2022 | Sale | 100 | 154.77 | 15,477 | I |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 20 Sep 2022 | Sale | 100 | 154.77 | 15,477 | I |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 102 | 158.1954 | 16,136 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 74 | 223.2333 | 16,519 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 100 | 180.74 | 18,074 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 100 | 184.17 | 18,417 | D |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 29 Dec 2022 | Sale | 91 | 225.1308 | 20,487 | D |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 129 | 159.7353 | 20,606 | D |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 29 Dec 2022 | Sale | 92 | 225.1297 | 20,712 | I |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 29 Dec 2022 | Sale | 92 | 225.1296 | 20,712 | I |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 100 | 210.18 | 21,018 | I |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 154 | 158.2368 | 24,368 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 111 | 225.2721 | 25,005 | D |
11 Jan 2023 16:50 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 11 Jan 2023 | Sale | 100 | 254 | 25,400 | D |
05 Sep 2024 17:40 | BGNE | BeiGene Ltd. | BALL TITUS B. | Principal Accounting Officer | 03 Sep 2024 | Sale | 137 | 189.9413 | 26,022 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 116 | 226.1511 | 26,234 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 195 | 158.5843 | 30,924 | D |
20 Jun 2024 17:24 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 17 Jun 2024 | Sale | 208 | 159.679 | 33,213 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 200 | 169.05 | 33,810 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 161 | 224.0403 | 36,070 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 181.365 | 36,273 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 182.625 | 36,525 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 237 | 158.5002 | 37,565 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 253 | 158.9981 | 40,227 | D |
10 Mar 2023 18:48 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 08 Mar 2023 | Sale | 200 | 226.6109 | 45,322 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 300 | 155.1492 | 46,545 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 300 | 156.8033 | 47,041 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 297 | 158.5309 | 47,084 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 300 | 159.9019 | 47,971 | D |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 192 | 250.2613 | 48,050 | I |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 192 | 250.2613 | 48,050 | D |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 193 | 250.2612 | 48,300 | I |
11 Jan 2023 16:50 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 11 Jan 2023 | Sale | 200 | 250.3872 | 50,077 | D |
20 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 17 Jun 2024 | Sale | 314 | 159.7408 | 50,159 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 275 | 188.9736 | 51,968 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 274 | 192.0435 | 52,620 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 307 | 180.2574 | 55,339 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 376 | 159.9113 | 60,127 | D |
26 Jun 2024 17:22 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 24 Jun 2024 | Sale | 400 | 160.1237 | 64,049 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 400 | 160.3782 | 64,151 | D |
04 Mar 2024 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 29 Feb 2024 | Sale | 397 | 167.08 | 66,331 | D |
03 Jul 2024 17:05 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 01 Jul 2024 | Sale | 472 | 143.8955 | 67,919 | D |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 450 | 153.1178 | 68,903 | I |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 450 | 153.1178 | 68,903 | I |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 478 | 158.9981 | 76,001 | D |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 500 | 152.349 | 76,174 | I |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 500 | 152.349 | 76,174 | I |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 17 Jun 2024 | Sale | 485 | 159.4241 | 77,321 | D |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 28 Dec 2022 | Sale | 366 | 224.7252 | 82,249 | I |
03 Mar 2023 17:00 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 01 Mar 2023 | Sale | 343 | 240.2096 | 82,392 | D |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 28 Dec 2022 | Sale | 367 | 224.7252 | 82,474 | I |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 28 Dec 2022 | Sale | 367 | 224.7252 | 82,474 | D |
11 Apr 2024 18:01 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 09 Apr 2024 | Sale | 542 | 152.2839 | 82,538 | I |
06 Jul 2023 17:02 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 03 Jul 2023 | Sale | 472 | 179.5495 | 84,747 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 478 | 182.6515 | 87,307 | D |
10 Mar 2023 18:48 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 08 Mar 2023 | Sale | 400 | 225.3475 | 90,139 | D |
20 Jun 2024 17:27 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 17 Jun 2024 | Sale | 608 | 159.3984 | 96,914 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 17 Jun 2024 | Sale | 627 | 158.9981 | 99,692 | D |
19 Sep 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 17 Sep 2024 | Sale | 500 | 200 | 100,000 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 531 | 223.2333 | 118,537 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 733 | 166.4439 | 122,003 | D |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 600 | 209.8817 | 125,929 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 18 Jun 2024 | Sale | 841 | 153.7512 | 129,305 | D |
05 Sep 2024 17:41 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 03 Sep 2024 | Sale | 700 | 191.2049 | 133,843 | D |
01 Aug 2024 17:06 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 30 Jul 2024 | Sale | 834 | 160.57 | 133,915 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 906 | 154.1722 | 139,680 | D |
26 Jun 2024 17:26 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 24 Jun 2024 | Sale | 899 | 155.66 | 139,938 | D |
15 Dec 2022 17:04 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 13 Dec 2022 | Sale | 665 | 212.3836 | 141,235 | I |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 700 | 204.2403 | 142,968 | I |
27 Jun 2023 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 23 Jun 2023 | Sale | 840 | 182.85 | 153,594 | D |
26 Jun 2024 17:24 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 24 Jun 2024 | Sale | 1,036 | 159.5297 | 165,273 | D |
26 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 24 Jun 2024 | Sale | 1,062 | 159.8 | 169,708 | D |
02 Aug 2023 17:10 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 31 Jul 2023 | Sale | 791 | 216.2567 | 171,059 | D |
20 Jun 2024 17:25 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 18 Jun 2024 | Sale | 1,121 | 153.6575 | 172,250 | D |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 835 | 207.622 | 173,364 | I |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 789 | 225.2721 | 177,740 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 993 | 179.3276 | 178,072 | D |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 884 | 205.5234 | 181,683 | I |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 824 | 226.1511 | 186,349 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 1,103 | 181.9144 | 200,652 | D |
15 Dec 2022 17:04 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 13 Dec 2022 | Sale | 956 | 211.6596 | 202,347 | I |
17 Nov 2022 17:10 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 15 Nov 2022 | Sale | 1,009 | 206.5129 | 208,372 | I |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 879 | 246.9661 | 217,083 | I |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 879 | 246.9958 | 217,109 | I |
12 Jan 2023 16:52 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 10 Jan 2023 | Sale | 879 | 246.9951 | 217,109 | D |
11 Jan 2023 16:50 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 09 Jan 2023 | Sale | 900 | 250 | 225,000 | D |
17 Jan 2023 17:13 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 12 Jan 2023 | Sale | 901 | 261.4811 | 235,594 | I |
11 Jan 2023 16:50 | BGNE | BeiGene Ltd. | WANG XIAODONG | Director | 11 Jan 2023 | Sale | 950 | 253.5674 | 240,889 | D |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 27 Dec 2022 | Sale | 1,119 | 224.2935 | 250,984 | I |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 27 Dec 2022 | Sale | 1,120 | 224.2936 | 251,209 | I |
29 Dec 2022 18:24 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 27 Dec 2022 | Sale | 1,120 | 224.2934 | 251,209 | D |
20 Jun 2023 18:53 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 20 Jun 2023 | Sale | 1,325 | 192.4192 | 254,955 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 1,147 | 224.0403 | 256,974 | D |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 1,716 | 151.1633 | 259,396 | I |
22 Sep 2022 17:34 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 21 Sep 2022 | Sale | 1,716 | 151.163 | 259,396 | I |
27 Jun 2023 17:20 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 26 Jun 2023 | Sale | 1,495 | 182.365 | 272,636 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)